Thomas Gerald Beach

Thomas Gerald Beach's AcademicInfluence.com Rankings

Thomas Gerald Beach

Medical

#1933

World Rank

#2320

Historical Rank

Neurology

#186

World Rank

#259

Historical Rank

medical Degrees

Download Badge

Medical

Thomas Gerald Beach's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Thomas Gerald Beach Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas Gerald Beach's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (2012) (2093)
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2011) (1839)
Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
Diagnosis and management of dementia with Lewy bodies (2017) (1606)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) (1494)
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease (1999) (1427)
Analysis of shared heritability in common disorders of the brain (2016) (1385)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
Primary age-related tauopathy (PART): a common pathology associated with human aging (2014) (988)
Use of florbetapir-PET for imaging beta-amyloid pathology. (2011) (938)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. (2013) (866)
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. (1999) (802)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012) (793)
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders (2010) (739)
Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease (2003) (721)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease (2010) (699)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (2012) (652)
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. (2006) (539)
A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. (2007) (521)
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (2009) (510)
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons (2008) (486)
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020) (463)
Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients (2004) (457)
GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers (2007) (452)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. (2020) (444)
Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism (2001) (416)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study (2015) (374)
Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2019) (372)
Low clinical diagnostic accuracy of early vs advanced Parkinson disease (2014) (363)
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy (2015) (340)
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. (2007) (318)
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease (2009) (308)
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
Patterns of gliosis in alzheimer's disease and aging cerebrum (1989) (307)
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. (2013) (307)
Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology (2014) (303)
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. (2007) (277)
Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease (2003) (274)
Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program (2015) (265)
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. (2008) (258)
Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. (2004) (256)
Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* (2001) (254)
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. (2007) (247)
Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease (2003) (246)
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. (2015) (238)
Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study (2013) (235)
The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007 (2007) (234)
Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† (2002) (233)
Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles (2006) (222)
Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production (2008) (219)
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative (2007) (218)
Role of Environmental Contaminants in the Etiology of Alzheimer's Disease: A Review (2015) (209)
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. (2012) (208)
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression (2020) (207)
Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. (2006) (195)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients (2003) (190)
Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects (2006) (188)
Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy (2001) (187)
SNAP-25 deficit and hippocampal connectivity in schizophrenia. (1998) (186)
Pathologic findings in prospectively ascertained essential tremor subjects (2008) (179)
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. (2020) (174)
Use of Florbetapir-PET for Imaging-Amyloid Pathology (2011) (172)
Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss (2012) (163)
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study (2018) (163)
Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease (2010) (162)
Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders (2008) (162)
Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology (2009) (160)
Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease (2004) (160)
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease (2006) (159)
Cerebral blood flow in Alzheimer’s disease (2012) (157)
Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. (2007) (157)
Evaluation of α-synuclein immunohistochemical methods used by invited experts (2008) (155)
Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes (2015) (154)
Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation (2020) (154)
Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia (2001) (151)
Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy (1995) (149)
Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies (2015) (145)
Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease (2012) (144)
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease (2000) (140)
Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. (2008) (139)
Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism (2000) (138)
Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. (2002) (138)
Does Parkinson’s disease start in the gut? (2017) (137)
Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene. (2010) (136)
Atherosclerosis of Cerebral Arteries in Alzheimer Disease (2004) (134)
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease (2015) (131)
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014) (127)
The distribution of substance P in the primate basal ganglia: An immunohistochemical study of baboon and human brain (1984) (125)
Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center (2005) (123)
Postmortem interval effect on RNA and gene expression in human brain tissue (2011) (120)
3‐hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis (2013) (120)
microRNA Profiles in Parkinson's Disease Prefrontal Cortex (2016) (119)
Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry (2014) (117)
Frequency of Alzheimer’s disease pathology at autopsy in patients with clinical normal pressure hydrocephalus (2011) (116)
Parkinson disease affects peripheral sensory nerves in the pharynx. (2013) (116)
Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With A&bgr; Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue (2012) (115)
Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes (2017) (114)
Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology (2016) (112)
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains (2013) (111)
[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology (2015) (110)
Alzheimer's disease a century later. (2006) (110)
Altered Pharyngeal Muscles in Parkinson Disease (2012) (109)
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease (2008) (107)
Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age (2019) (106)
Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer’s disease (2011) (105)
Evidence for an association between KIBRA and late-onset Alzheimer's disease (2010) (105)
Concomitant pathologies among a spectrum of parkinsonian disorders. (2014) (104)
Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex (1988) (103)
Submandibular gland needle biopsy for the diagnosis of Parkinson disease (2014) (103)
Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis (2021) (103)
Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects (2014) (102)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. (2013) (99)
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease (2018) (98)
Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity (2018) (98)
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. (2011) (97)
Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease (2014) (97)
Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. (2007) (96)
Submandibular gland biopsy for the diagnosis of Parkinson disease. (2013) (95)
Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease (2015) (91)
In vitro high affinity α-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1 (2008) (89)
Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia (2009) (88)
The history of Alzheimer's disease: three debates. (1987) (86)
Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains. (2004) (85)
Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity (2014) (85)
Amyloid load in nondemented brains correlates with APOE e4 (2010) (85)
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations (2013) (85)
Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies (2013) (83)
Parkinson disease and incidental Lewy body disease (2015) (83)
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
Diagnosis of prostate cancer using differentially expressed genes in stroma. (2010) (83)
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers (2014) (82)
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease (2011) (81)
Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level (2021) (80)
Sorl1 as an Alzheimer’s Disease Predisposition Gene? (2007) (78)
Essential tremor is not associated with cerebellar Purkinje cell loss (2014) (78)
Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology. (2011) (77)
Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer’s disease? (1997) (77)
Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation (1987) (76)
Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits (2007) (75)
Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment (2010) (75)
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection (2016) (75)
An animal model of prophylactic cranial irradiation: histologic effects at acute, early and delayed stages. (1990) (74)
Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (73)
TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies (2013) (73)
Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology (2010) (73)
Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex (2015) (73)
Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease (2019) (72)
Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation (2012) (72)
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. (2000) (71)
Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD. (2010) (71)
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. (2015) (71)
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease (2009) (70)
Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging (2011) (69)
APP/Aβ structural diversity and Alzheimer's disease pathogenesis (2017) (69)
Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome. (2011) (68)
Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease (1998) (68)
Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (67)
The Search for a Peripheral Biopsy Indicator of &agr;-Synuclein Pathology for Parkinson Disease (2017) (67)
Graph theory network function in Parkinson’s disease assessed with electroencephalography (2016) (67)
Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition (2000) (67)
Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database (2013) (67)
Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains (2020) (66)
Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease. (2014) (64)
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition (2016) (64)
Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists (2001) (64)
JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer Cells. (2016) (63)
Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging. (2012) (63)
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD (2019) (63)
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects (2012) (63)
Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (62)
Soluble Amyloid b Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease (1999) (61)
Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects. (2016) (61)
Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies (2012) (61)
Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. (2006) (61)
Blinded RT‐QuIC Analysis of α‐Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients (2020) (60)
Systematic Optimization of Long Gradient Chromatography Mass Spectrometry for Deep Analysis of Brain Proteome (2014) (60)
Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies (2016) (60)
Increased CSF biomarkers of angiogenesis in Parkinson disease (2015) (59)
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease (2017) (59)
Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's disease (2006) (59)
Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. (2014) (59)
Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) (59)
Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings (2016) (59)
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations (2008) (58)
Chemical phenotype of calretinin interneurons in the human striatum (1998) (57)
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease (2021) (57)
Importance of low diagnostic Accuracy for early Parkinson's disease (2018) (56)
The Evolution of Aβ Peptide Burden in the APP23 Transgenic Mice: Implications for Aβ Deposition in Alzheimer Disease (2001) (55)
Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers (2004) (54)
Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease. (2011) (53)
Do cholinergic therapies have disease-modifying effects in Alzheimer’s disease? (2006) (52)
Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. (2011) (52)
Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease (2014) (52)
Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. (2013) (52)
Alzheimer Disease: Scientific Breakthroughs and Translational Challenges (2017) (51)
Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease (2018) (50)
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease (2020) (50)
Essential tremor and Parkinson's disease: Lack of a link (2011) (50)
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease (2021) (49)
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau (2021) (49)
Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease. (2012) (49)
Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition (2000) (49)
Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders. (2016) (48)
Laser-captured microglia in the Alzheimer's and Parkinson's brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer's brain (2018) (48)
PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease (2015) (48)
Brain proteome-wide association study implicates novel proteins in depression pathogenesis (2021) (48)
Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies (2016) (47)
Expression and Localization of Mitochondrial Ferritin mRNA in Alzheimer's Disease Cerebral Cortex (2011) (47)
Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease. (2015) (46)
Effect of ApoE isoforms on mitochondria in Alzheimer disease (2020) (45)
Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition. (2018) (45)
Increased expression of the urokinase plasminogen-activator receptor in amyloid β peptide-treated human brain microglia and in AD brains (2002) (45)
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease. (2017) (44)
27-plex Tandem Mass Tag Mass Spectrometry for Profiling Brain Proteome in Alzheimer's Disease. (2020) (44)
The biochemical aftermath of anti-amyloid immunotherapy (2010) (43)
Simplified conversion method for unified Parkinson's disease rating scale motor examinations (2015) (43)
Impaired hepatic amyloid-beta degradation in Alzheimer’s disease (2018) (43)
Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease (2018) (43)
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations (2013) (43)
Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia? (2009) (42)
Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors. (2002) (42)
Striatal neurones displaying substance P (NK1) receptor immunoreactivity in human and non-human primates. (1995) (42)
Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue (2016) (42)
Small‐Amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations (2002) (41)
Light microscopic evidence for a substance P-containing innervation of the human nucleus basalis of Meynert (1987) (41)
Molecular Differences and Similarities Between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis (2013) (41)
The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease. (2016) (40)
Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? (2011) (40)
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program (2016) (40)
Calretinin-immunoreactive neurons in the human striatum (1995) (39)
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes. (2019) (38)
MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy (2017) (37)
Neurochemical profile of dementia pugilistica. (2013) (37)
Revealing the brain's molecular architecture. (2018) (37)
Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome (2015) (36)
Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases (1998) (36)
Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine (2001) (35)
Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging. (2019) (35)
Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment (2015) (35)
TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. (2007) (34)
Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging. (2012) (34)
Patients With Alzheimer Disease Have Altered Transmitral Flow (2009) (34)
Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations. (2014) (34)
Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition (2018) (34)
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. (2014) (34)
Correlation of Clinical Features With Argyrophilic Grains at Autopsy (2009) (33)
Pathology in essential tremor. (2012) (33)
The distribution of phosphorylated tau in spinal cords of Alzheimer's disease and non-demented individuals. (2013) (33)
Evaluation of Parkinson Disease Risk Variants as Expression-QTLs (2012) (33)
A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley? (2017) (33)
Progressive Aphasia with Lewy Bodies (2002) (33)
Infiltration of T Lymphocytes and Expression of ICAM-1 in the Hippocampus of Patients with Hippocampal Sclerosis (2010) (33)
Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects. (2009) (32)
Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson’s Disease Patients (2015) (32)
Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease (2009) (32)
Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease (2018) (32)
Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients (2009) (31)
Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy (2013) (31)
Immunohistochemical localization of nicotinic β2 and α4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations (1998) (31)
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure (2021) (31)
Neocortical substance P neurons in the baboon: An immunohistochemical finding (1983) (30)
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression (2018) (30)
Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease (2020) (30)
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism (2020) (30)
Altered APP Processing in PDAPP (Val717 → Phe) Transgenic Mice Yields Extended-Length Aβ Peptides. (2005) (29)
Presenilin-1 280Glu→Ala Mutation Alters C-Terminal APP Processing Yielding Longer Aβ Peptides: Implications for Alzheimer’s Disease (2008) (29)
Amyloidogenic Medin Induces Endothelial Dysfunction and Vascular Inflammation Through the Receptor for Advanced Glycation Endproducts (2017) (29)
Autonomic complaints in patients with restless legs syndrome. (2013) (28)
Theoretical Impact of Florbetapir (18F) Amyloid Imaging on Diagnosis of Alzheimer Dementia and Detection of Preclinical Cortical Amyloid (2014) (28)
GBA mutations in Parkinson disease: earlier death but similar neuropathological features (2017) (28)
Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy. (2008) (28)
Induction of pluripotent stem cells from autopsy donor-derived somatic cells (2011) (28)
Alzheimer’s patient brain myeloid cells exhibit enhanced aging and unique transcriptional activation (2019) (28)
Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4) (2018) (27)
Thiorphan-induced neprilysin inhibition raises amyloid β levels in rabbit cortex and cerebrospinal fluid (2003) (27)
Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology (2019) (27)
The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target (2018) (27)
Physiologic Origins of Age-Related β-Amyloid Deposition (2008) (26)
Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation (2017) (26)
Senile plaques, amyloid β-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex (2004) (26)
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
Cortical cholinergic denervation elicits vascular A beta deposition. (2000) (26)
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology (2017) (26)
Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study (2018) (25)
Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia (2019) (25)
Next-generation profiling to identify the molecular etiology of Parkinson dementia (2016) (25)
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (25)
Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. (2020) (25)
Heritability and genetic variance of dementia with Lewy bodies (2018) (25)
An association with great implications: vascular pathology and Alzheimer disease. (2006) (24)
Tau immunoreactivity in peripheral tissues of human aging and select tauopathies (2019) (24)
The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease (2013) (24)
Alzheimer's disease and the "Valley Of Death": not enough guidance from human brain tissue? (2012) (23)
TMEM106B haplotypes have distinct gene expression patterns in aged brain (2018) (23)
In vitro-differentiated neural cell cultures progress towards donor-identical brain tissue. (2013) (23)
Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases (2016) (23)
A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor (2017) (23)
Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient. (2011) (23)
Alzheimer’s Disease Research Using Human Microglia (2019) (22)
Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels (2022) (22)
Altered APP processing in PDAPP (Val717 --> Phe) transgenic mice yields extended-length Abeta peptides. (2005) (22)
Identification of Circular RNAs using RNA Sequencing. (2019) (21)
Cholinergic fiber loss occurs in the absence of synaptophysin depletion in Alzheimer's disease primary visual cortex (1992) (21)
Vagus Nerve and Stomach Synucleinopathy in Parkinson Disease, Incidental Lewy Body Disease and Normal Elderly Subjects: Evidence Against the Body-First Hypothesis (2020) (21)
A single cell-based atlas of human microglial states reveals associations with neurological disorders and histopathological features of the aging brain (2018) (21)
Genetic analysis of α-synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies (2017) (21)
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia (2019) (20)
Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study (2021) (20)
Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease (2003) (20)
Alzheimer’s Disease Neuropathological Comorbidities Are Common in the Younger-Old (2020) (20)
Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions. (2014) (20)
Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study (2020) (19)
A case study of temporal lobe development in familial schizophrenia (1996) (19)
Correlation of the Expression Level of C1q mRNA and the Number of C1q-Positive Plaques in the Alzheimer Disease Temporal Cortex (2001) (19)
Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer’s Disease: Analysis of 13 Cases (2016) (19)
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression (2020) (18)
Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer’s Disease (2016) (18)
Intracranial Atherosclerosis as a contributing factor to Alzheimer's disease Dementia (2009) (18)
Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway (2017) (18)
Phosphorylated TDP-43 in frontotemporal lobar degeneration and ALS (2009) (18)
Bid signal pathway components are identified in the temporal cortex with Parkinson disease (2012) (18)
Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease (2019) (18)
Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease (2020) (17)
Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls. (2021) (17)
The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane (2016) (17)
Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease. (2011) (17)
Tract-tracing with horseradish peroxidase in the postmortem human brain (1987) (17)
Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. (2018) (17)
A comprehensive screening of copy number variability in dementia with Lewy bodies (2019) (16)
Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease (2011) (16)
Assessment of APOE in atypical parkinsonism syndromes (2019) (16)
Alpha-synuclein: prion or prion-like? (2019) (15)
Essential Tremor in the Elderly and Risk for Dementia (2014) (15)
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations. (2013) (15)
Ventral striatal D3 receptors and Parkinson's Disease (2001) (15)
Increased β-amyloid precursor protein mRNA in the rat cerebral cortex and hippocampus after chronic systemic atropine treatment (1996) (15)
[18F]FLUTEMETAMOL AMYLOID PET IN SYMPTOMATIC ALZHEIMER'S DISEASE (AD) AND PATHOLOGICALLY PRECLINICAL AD (P-PREAD) IN COMPARISON TO NON-AD CONTROLS: IMPACT OF CEREBRAL AMYLOID ANGIOPATHY (2014) (15)
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (2018) (14)
Lamina-selective A68 immunoreactivity in primary visual cortex of Alzheimer's disease patients (1989) (14)
Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease (2014) (14)
The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology (2003) (14)
Myoclonus in Lewy body disorders. (2002) (14)
SMG1 Identified as a Regulator of Parkinson’s Disease-Associated alpha-Synuclein through siRNA Screening (2013) (14)
A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease (2020) (14)
A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases (2016) (13)
Muscarinic agonists as preventative therapy for Alzheimer's disease. (2002) (13)
Deep Profiling of Microgram-Scale Proteome by Tandem Mass Tag Mass Spectrometry. (2020) (13)
Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease (2017) (13)
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies (2017) (13)
Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets (2020) (13)
Incidental Lewy body disease: Electrophysiological findings suggesting pre-clinical Lewy body disorders (2011) (12)
Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR. (2012) (12)
Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways (2019) (12)
Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing Nanoliposomes (2020) (12)
Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy (2014) (12)
Multicentre phase 3 trial on florbetaben for beta-amyloid brain PET in Alzheimer's disease (2012) (12)
Association of AEBP1 and NRN1 RNA expression with Alzheimer’s disease and neurofibrillary tangle density in middle temporal gyrus (2019) (12)
Sirtuin 3 Mediates Tau Deacetylation. (2019) (12)
Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease. (2019) (11)
Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease. (2019) (11)
Featured Articles National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (2012) (11)
Nanoliposomes protect against human arteriole endothelial dysfunction induced by β-amyloid peptide (2016) (11)
Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat. (2014) (11)
Calretinin gene expression in the human thalamus. (1998) (11)
Retrograde filling of pyramidal neurons in postmortem human cerebral cortex using horseradish peroxidase (1988) (11)
Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin (2019) (11)
Spatially resolved transcriptomics reveals unique gene signatures associated with human temporal cortical architecture and Alzheimer’s pathology (2021) (10)
Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype (2017) (10)
Phase III trial results for the amyoid PET imaging agent Florbetapir F 18 (18F-AV-45): imaging to histopathologic correlations in an end-of-life human subject study (2010) (10)
Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies (2021) (10)
Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology (2013) (10)
Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment (2020) (10)
Genome-wide association study and functional validation implicates JADE1 in tauopathy (2021) (10)
Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab. (2016) (10)
Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease. (2021) (9)
The Impact of Aging on Brain Pituitary Adenylate Cyclase Activating Polypeptide, Pathology and Cognition in Mice and Rhesus Macaques (2017) (9)
BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains. (2013) (9)
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia (2022) (9)
Ventral striatal D(3) receptors and Parkinson's Disease. (2001) (9)
Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients (2015) (9)
Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases (2015) (9)
Differential expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits by calretinin-immunoreactive neurons in the human striatum (1999) (9)
Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia (2020) (8)
Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence (2022) (8)
Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. (2010) (8)
Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains (2021) (8)
Short Elevated A b 42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of A b PP Metabolism (2000) (8)
Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings (2017) (8)
Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40. (2018) (8)
Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia. (2018) (8)
Assessment of persistent, bioaccumulative and toxic organic environmental pollutants in liver and adipose tissue of Alzheimer's disease patients and age- matched controls. (2019) (7)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium (2021) (7)
Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case report. (2020) (7)
Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19 (2021) (7)
Clinical Diagnostic Accuracy of Early/Advanced Parkinson Disease: An Updated Clinicopathologic Study. (2020) (6)
Variability of diffuse plaques and amyloid angiopathy in Parkinson’s disease with mild cognitive impairment (2010) (6)
Interpretable deep learning of myelin histopathology in age-related cognitive impairment (2022) (6)
Prevalence of REM sleep behavior disorder in Sun City, Arizona (2020) (6)
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies (2021) (6)
Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168 (2017) (6)
Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s Disease (2021) (6)
Acute Brain Ischemia, Infarction and Hemorrhage in Subjects Dying with or Without Autopsy-Proven Acute Pneumonia (2021) (5)
Disassembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients (2009) (5)
Sirtuin 3 is down-regulated in Apolipoprotein E4 carriers with Alzheimer’s disease (P5.011) (2015) (5)
Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness (2021) (5)
The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease. (2016) (5)
Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients (2021) (5)
Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease (2018) (5)
ESHRD: deconvolution of brain homogenate RNA expression data to identify cell-type-specific alterations in Alzheimer’s disease (2020) (4)
Hippocampal synaptic pathology in patients with temporal lobe epilepsy (1994) (4)
Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body disease (2020) (4)
Contrast Acuity With Different Colors in Parkinson's Disease (2019) (4)
NEUROFIBRILLARY TANGLE PREDOMINANT DEMENTIA: CLINICAL AND PATHOLOGICAL DESCRIPTION IN A CASE SERIES (2016) (4)
Effect of olfactory bulb pathology on olfactory function in normal aging (2022) (4)
Featured Articles Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease (2009) (4)
Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy (2021) (4)
Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease (2021) (4)
Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease (2018) (4)
O4-03-06 Cortical cholinergic deficit is associated with plaque development at preclinical stages of Alzheimer's disease (2004) (4)
2.13.1 PATHOLOGY IN ESSENTIAL TREMOR (2012) (4)
Role of Astrocyte Dysfunction in Epilepsy (2009) (4)
Erratum to: Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue (2016) (3)
Brain Lewy-Type Synucleinopathy Density Is Associated with a Lower Prevalence of Atherosclerotic Cardiovascular Disease Risk Factors in Patients with Parkinson's Disease1. (2019) (3)
Correction: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology (2014) (3)
[Significance of the TDP-43 deposition in FTLD-U and ALS]. (2008) (3)
A transcriptome-wide association study identifies novel blood-based gene biomarker candidates for Alzheimer's disease risk. (2021) (3)
Florbetapir (18F-AV-45) PET imaging of {beta}-amyloid plaques is highly correlated with histopathological assays at autopsy (2010) (3)
Phospho‐tau217 and phospho‐tau181 in plasma and CSF as biomarkers for Alzheimer’s disease (2020) (3)
Neurofibrillary Tangle Predominant Dementia: Clinical andPathological Description in a Case Series (2016) (3)
Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (2018) (2)
Clinicopathologic Correlations in 172 Cases of REM Sleep Behavior Disorder ± a Coexisting Neurologic Disorder (PL01.003) (2013) (2)
Microglial and Astrocytic Reactions in Alzheimer’s Disease (2002) (2)
Correlation Between the Movement Disorder Society's Unified Parkinson's Disease Rating Scale and Nonmotor Scales in Patients with Parkinson's Disease. (2019) (2)
Neuroimagenomics for the Study of Human Obesity (2006) (2)
Echocardiography vortex formation time reveal cardiac diastolic transmitral flow dysfunction in Alzheimer's disease patients (2009) (2)
White Matter Beta-Amyloid Precursor Protein Immunoreactivity in Autopsied Subjects With and Without COVID-19 (2021) (2)
Morphological and biochemical analysis of the 3xTg-Alzheimer's disease mouse model: Implications for sporadic Alzheimer's disease and the amyloid cascade hypothesis (2011) (2)
COMPARISON OF REGIONAL FLORTAUCIPIR PET TO QUANTITATIVE TAU AND AMYLOID IMMUNOASSAY IN PATIENTS WITH ALZHEIMER’S DISEASE PATHOLOGY: A PILOT CLINICO-PATHOLOGICAL STUDY (2017) (2)
An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson’s Disease (2021) (2)
CHANGES IN TAU PROTEIN LANDSCAPE DURING ALZHEIMER’S DISEASE PROGRESSION (2017) (2)
Characteristics of people misdiagnosed with Alzheimer's disease and their medication use: An analysis of the National Alzheimer's Coordinating Center Uniform Data Set database (2013) (2)
Clonal Evolution of a Case of Treatment Refractory Maxillary Sinus Carcinoma (2012) (2)
A Modification of the Bielschowsky Silver Stain for Alzheimer Neuritic Plaques: Suppression of Artifactual Staining by Pretreatment with Oxidizing Agents (2019) (2)
A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with NTNG1 and CNOT3 (2021) (2)
Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease (2018) (1)
Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer’s Disease (2023) (1)
Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate? (2020) (1)
Detection of beta-Amyloid by Florbetaben PET: Histopathological Verification in a Global Phase 3 Clinical Trial (2012) (1)
Salivary Gland Biopsy as a Diagnostic Test for Parkinson's Disease (IN2-1.002) (2013) (1)
HETEROGENEITY IN TAU, AMYLOID AND CO-MORBID PATHOLOGIES IN ALZHEIMER'S DISEASE (2017) (1)
Comparison of florbetapir-PET scans to postmortem beta-amyloid histopathology in 59 autopsy cases (2012) (1)
Alterations of the Sensory and Cognitive Components of Operative Memory in a Monkey Model of Alzheimer's Disease (2003) (1)
Decreased Levels of Beta‐Arrestin 1 in Brains of Patients with Alzheimer's Disease (2018) (1)
Expression and localization of lactotransferrin mRNA in the cortex of Alzheimer’s disease (2009) (1)
ACValidator: A novel assembly-based approach for in silico verification of circular RNAs (2020) (1)
Further methodological problems in cell counting (1987) (1)
brain human functionally distinct regions of the normal aged Gene expression profiles in anatomically and (2015) (1)
ACValidator: a novel assembly-based approach for in silico validation of circular RNAs (2019) (1)
Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease. (2021) (1)
THE HUMAN BRAINOME: HUMAN BRAIN GENOME, TRANSCRIPTOME, AND PROTEOME INTEGRATION (2016) (1)
Abstract 2187: A rapid autopsy program for cancer research (2018) (1)
Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease? (2018) (1)
Diagnostic value of [18F]flutemetamol amyloid PET: comparison between imaging and neuropathology (2014) (1)
Response to Parkinnen et al. and Jellinger (2009) (1)
Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research (2020) (1)
TEMPORAL LOBE QUANTITATION OF FLORTAUCIPIR PET IMAGES MAY IMPROVE DETECTION OF INTERMEDIATE NEUROFIBRILLARY TANGLE PATHOLOGY IN AUTOPSY-VALIDATED CASES (2019) (1)
Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology (2015) (1)
Clinical and Neuropathological Correlates of Visual Hallucinations in Parkinsonism (2013) (1)
Hemispheric asymmetry and atypical lobar progression of Alzheimer‐type tauopathy (2022) (1)
Impaired Processes of Working Memory in the Monkey Model of Alzheimer's Disease (2002) (1)
Profiling the NOTCH2NLC GGC Repeat Expansion in Parkinson's Disease in the European Population (2022) (1)
Deep multilayer brain proteomics identifies molecular networks and Netrin‐1 accumulation in Alzheimer’s disease progression (2020) (1)
Heart rate variability as a screening tool for Parkinson’s disease has age-dependent performance (P1.110) (2017) (1)
INCREASED EXPRESSION OF TOLL-LIKE RECEPTOR (TLR)-3 IN ALZHEIMER’S DISEASE BRAINS: A PROTECTIVE OR PATHOGENIC RESPONSE? (2017) (1)
Lewy bodies are incidental in essential tremor. (2016) (1)
Tg-SwDI Transgenic Mice Exhibit Novel Alterations in A (cid:1) PP Processing, A (cid:1) Degradation, and Resilient Amyloid Angiopathy (2008) (1)
Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau (2020) (1)
Deficiency of WFS1 increases vulnerability to pathological tau in vitro and in vivo (2020) (1)
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies. (2021) (1)
Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment (2022) (1)
Faculty Opinions recommendation of Solvent exposures and Parkinson disease risk in twins. (2012) (0)
Amyloid Imaging with Florbetapir F 18 (18F-AV-45) PET in a subject with Down's Syndrome and Alzheimer's disease at the End of Life (2010) (0)
Is there an increased risk of death from natural causes in young adult apolipoprotein E epsilon 4 carriers? (2010) (0)
Differential expression of tumor necrosis factor (TNF) α between the temporal and cerebellar cortices of people with Alzheimer's disease compared with alterations in TNF receptor expression (2013) (0)
APOE4 NON-CARRIERS WITH THE CLINICAL DIAGNOSIS OF ALZHEIMER'S DEMENTIA AND MINIMAL AMYLOID HISTOPATHOLOGY (2014) (0)
Selective deafferentation of the rabbit cortex: A new animal model of Alzheimer's disease (2000) (0)
Alzheimer's disease subjects carrying the APOE4 allele have lower brain BACE1 levels than APOE3 carriers (2011) (0)
Comparison of clinical and neuropathological definitions of alzheimer's disease at national institute on aging Alzheimer's disease centers, 2005-2010 (2011) (0)
P1-474: Membrane bound Aβ peptides in Alzheimer's disease and nondemented subjects (2008) (0)
PT581. Multiple accumulation of neurodegenerative disease-related proteins in familial granulin mutation brains (2016) (0)
Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study (2022) (0)
Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation. (2021) (0)
P3-256 Mechanism of neurofibrillary tangle-induced neuronal degeneration leading to Ad (2004) (0)
Metabolic profiling of neocortical tissue discriminates Alzheimer’s disease from mild cognitive impairment, high pathology controls, and normal controls (2020) (0)
Inflammatory Mechanisms in Alzheimer'S Disease and Other Neurodegenerative Disorders (2008) (0)
Is beta‐arrestin related to muscarinic receptor uncoupling in Alzheimer's disease? (153.4) (2014) (0)
Polygenic risk scores can predict AD‐related pathologies (2020) (0)
PACAP Deficit in Alzheimer's Disease and Protection Against Beta-Amyloid Toxicity (I11-1.010) (2014) (0)
receptors and the PI3K-Akt pathway in the case of galantamine and donepezil but not for rivastigmine. P4-296 AMYLOID- PEPTIDE REMNANTS IN AN-1792- IMMUNIZED ALZHEIMER’S DISEASE PATIENTS (2006) (0)
JAMA Neurology Peer Reviewers in 2016. (2017) (0)
P3-275 Expression and regulation of inflammatory genes in human brain endothelial cells induced by beta-amyloid peptides (2006) (0)
Abstract 18245: Palmitic Acid-induced Endothelial Dysfunction in Human Leptomeningeal and Adipose Arterioles (2015) (0)
IMMUNOPHENOTYPING OF MICROGLIA: CHARACTERIZATION OF A VARIANT OF CD105 AS A MARKER OF ACTIVATED MICROGLIA IN ALZHEIMER’S DISEASE AND AGED BRAINS (2019) (0)
miRNA Biomarker Identification Using a Sequencing-Based Nuclease Protection Assay (NPSeq™) (2013) (0)
Cortical Cholinergic Deafferentation Induces Aβ Deposition (2005) (0)
Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia (2020) (0)
THE DISTINCT CONTRIBUTION OF SNCA-3′UTR TO PARKINSON’S AND DEMENTIA WITH LEWY BODIES (2017) (0)
[Frontotemporal dementia (FTD) and genetic mutations including progranulin gene]. (2008) (0)
Toronto: HAI Amyloid Imaging Conference Abstracts This concludes a six-part series of the HAI Amyloid Imaging Conference. See also (2010) (0)
FUNCTIONAL, GLOBAL, AND COGNITIVE DECLINE CORRELATES TO ACCUMULATION OF ALZHEIMERʼS PATHOLOGY.: 9. (2006) (0)
Neuropathological outcome of prospectively followed normal elderly brain bank volunteers (2013) (0)
Neural Cell Degeneration in Human Retinas May Explain Visual Dysfunction in Parkinson Disease (2017) (0)
Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology (2019) (0)
An immunohistochemical study of the substance P neuronal system in the primate brain : basal ganglia and neocortex (1984) (0)
Repeat Submandibular Gland Biopsies as a Progression Marker in Parkinson’s Disease (S10.002) (2019) (0)
HUMAN CHOROID PLEXUS INFLAMMATORY FEATURES: A STUDY IN POSTMORTEM CHOROID PLEXUS TISSUES AND EPITHELIAL CELLS (2018) (0)
Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study (2018) (0)
Color vision and contrast sensitivity in Parkinson Disease (P1.041) (2018) (0)
Biochemical consequences of traumatic brain injury in dementia pugilistica (2012) (0)
Clinicopathological Correlates of Verbal Fluency in Parkinson’s Disease: A Pilot Study (P3.197) (2018) (0)
111 Hippocampal presynaptic proteins in schizophrenia (1997) (0)
Abstract 380: Impairment of Human Microvascular Function Induced by β-amyloid and Cardiovascular Risk Factors (2016) (0)
Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies (2013) (0)
Endothelial Dysfunction in Leptomeningeal and Peripheral Arterioles Induced by beta-amyloid Peptides: A Novel Human Model to Study Alzheimer's Disease (2013) (0)
A b structural diversity and Alzheimer ' s disease pathogenesis (2017) (0)
Spatially Resolved Transcriptomics Reveals Gene Signatures Underlying the Vulnerability of Human Middle Temporal Gyrus in Alzheimer's Disease (2021) (0)
Abstract 2735: Diagnosis of prostate cancer without tumor cells using differentially expressed genes in the tumor microenvironment (2010) (0)
Carotid artery stenosis as a risk factor for Alzheimer’s disease (2020) (0)
Risk of Developing Dementia in Essential Tremor (S53.004) (2013) (0)
Correlation of cerebrospinal fluid cytokines with cortical microglia densities in clinicopathological Alzheimer's disease and cognitively normal individuals (2012) (0)
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression (2018) (0)
Abstract TMP96: Determining the Relationship Between Cognitive Function and ex-vivo Leptomeningeal Arteriole Function: A Study in Rapid Autopsy Brain Donors (2018) (0)
Alzheimer's disease and the Valley of Death: Not enough guidance from human brain tissue? (2012) (0)
P2-168 Can neuropathological and nicotinic receptor binding differences distinguish mild cognitive impairment from Alzheimer’s disease and normal aging? (2006) (0)
The interaction of beta-amyloid with alpha1-chimaerin involved in the pathogenesis of Alzheimer's disease (2011) (0)
Prevalence Of Lewy-Type Synucleinopathy In The Submandibular Gland Of Subjects With Neuropathologically-Confirmed Dementia With Lewy Bodies. (S38.007) (2014) (0)
P4-296 Amyloid-β peptide remnants in AN-1792-immunized Alzheimer’s disease patients (2006) (0)
Abstract 14270: Medin Amyloid, but Not β-amyloid, Induces Pro-Inflammatory Signaling in Endothelial Cells That is Synergistic With Palmitic Acid (2017) (0)
Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near ZIC1 and ZIC4 (2021) (0)
Reliable Detection Of Striatal Amyloid With [18F] Flutemetamol: Validation With Postmortem Histopathology (P6.328) (2014) (0)
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal dementia and GRN mutations : a genome-wide association study (2018) (0)
THE EFFECT OF SIRTUIN 3 ON TAU ACETYLATION IN ALZHEIMER'S DISEASE (2018) (0)
Membrane rafts in the oldest old (2011) (0)
Type 2 diabetes is associated with increased Alzheimer’s disease neuropathology in ApoE ε 4 Carriers (2014) (0)
Abstract 10470: Endothelial Dysfunction in Leptomeningeal and Peripheral Arterioles Induced by ß-amyloid Peptides: A Novel Human Model to Study Alzheimer’s Disease (2013) (0)
STRIATAL AMYLOID VIA [18F]FLUTEMETAMOL PREDICTS CONVERSION FROM AMCI TO PAD (2019) (0)
LARGE-SCALE PROTEOMIC ANALYSIS OF HUMAN PREFRONTAL CORTEX IDENTIFIES PROTEINS ASSOCIATED WITH COGNITIVE TRAJECTORY IN ADVANCED AGE (2019) (0)
Clinical Features Predict Lewy Body Pathology and Differentiate between Different Pathologies: A Clinical-Pathologic Prospective Study (P6.231) (2016) (0)
Whole-Cell Dissociated Suspension Analysis in Human Brain Neurodegenerative Disease: A Pilot Study (2021) (0)
Longitudinal motor decline in dementia with Lewy bodies and Parkinson’s disease dementia in a community autopsy cohort (2021) (0)
P2-192: Accumulation of phosphorylated TDP-43 in neurodegenerative disorders (2008) (0)
Neuropathological Correlates of Visual Hallucinations in Parkinsonism (S03.006) (2013) (0)
INCREASED ß-APP IN HIPPOCAMPUS AND CORTEX AFTER CHRONIC SYSTEMIC ATROPINE TREATMENT (1996) (0)
Low diagnostic accuracy for an early clinical diagnosis of Parkinson's Disease (2020) (0)
Edinburgh Research Explorer In Vivo Distribution of -Synuclein In Multiple Tissues and Biofluids in Parkinson’s Disease (0)
[18F]T807 ([18F]AV-1451) and Fluorescent Analog T726 Bind to PHF-Tau but Not TDP-43 in Alzheimer’s and FTD Post-Mortem Brain Tissue Sections (2015) (0)
Restless legs syndrome (RLS) shows increased post-mortem microvascular disease in cortex compared to controls (2019) (0)
How does diabetes affect plaque and tangle pathology in Alzheimer's Disease? (2011) (0)
Cognitive Dysfunction, Dementia and Emotional Disturbances (2009) (0)
Abstract WP416: Comparison of Ex-vivo Human Leptomeningeal Arteriole Function in Cognitively Normal and Dementia Disorders From Rapid Autopsy Brain Donors (2018) (0)
Cortical Cholinergic Lesion Causes Aβ Deposition: Cholinergic-Amyloid Fusion Hypothesis (2008) (0)
Neuropathological and biochemical characterization of the oldestold with and without Alzheimer's disease (2011) (0)
EXCEPTIONALLY LOW RISK OF ALZHEIMER’S DEMENTIA IN APOE2 HOMOZYGOTES (2019) (0)
Genome-wide association analysis of Dementia with Lewy bodies reveals unique genetic architecture (2017) (0)
P4-103 Atherosclerosis of cerebral arteries in the pathogenesis of Alzheimer’s disease (2006) (0)
IDENTIFICATION OF SYNAPTIC TAU ANTIBODIES IN ALZHEIMER'S DISEASE AND RELATED TAUOPATHIES (2018) (0)
PHOSPHORYLATED TAU AND ALPHA-SYNUCLEIN ACCUMULATION IN FAMILIAL GRANULIN MUTATION CASES (2016) (0)
Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learning (2020) (0)
Medin Amyloid, but Not beta-amyloid, Induces Pro-Inflammatory Signaling in Endothelial Cells That is Synergistic With Palmitic Acid (2017) (0)
Frontal and Hippocampal Tangles and Plaque Density Are Associated with Anosognosia in Alzheimer Disease (P05.051) (2012) (0)
THE PRESENCE OF NEURONAL PROTEINS IN HUMAN SUBMANDIBULAR GLAND IN ALZHEIMER’S DISEASE AND NONDEMENTED INDIVIDUALS (2018) (0)
Genes in Stroma Diagnosis of Prostate Cancer Using Differentially Expressed (2011) (0)
Transcranial Dopplerultrasoundbloodflowvelocityandpulsatilityindex as systemic indicators for Alzheimer's disease (2011) (0)
PACAP deficit and Cognitive Function in Mild Cognitive Impairment and Alzheimer Dementia (P4.084) (2015) (0)
Neurodegenerative-related proteins in the evolution of the aging brain (2012) (0)
TWO DECADES OF RESEARCH USING POSTMORTEM HUMAN MICROGLIA: FINDINGS AND EXPERIENCES FROM BANNER SUN HEALTH RESEARCH INSTITUTE RAPID AUTOPSY PROGRAM (2019) (0)
S2-04-01 The therapeutic potential of M1 muscarinic agonists in Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA) (2004) (0)
Featured Article Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease (2016) (0)
Peripheral Adipose Arteriole Dilator Response to Amyloid Proteins and Palmitic Acid Recapitulates Central Leptomeningeal Arteriole Response: Validation of a Novel Human Tissue Model (2018) (0)
Reduced CD 59 expression is associated with high membrane attack complex ( MAC ) levels in neurons of Alzheimer ’ s disease (2018) (0)
Title The influence of Apolipoprotein E genotype on regional pathology in Alzheimer ' s disease (2013) (0)
Striatal amyloid plaque density predicts braak neurofibrillary tangle stage and clinicopathological Ad: Implications for amyloid imaging (2011) (0)
Neuropathological diagnoses of subjects autopsied in the phase 3 clinicopathological study of flortaucipir F18 PET imaging (2020) (0)
The Pituitary Adenylate Cyclase Activating Polypeptide Levels are Associated with Pathological Features of Alzheimer’s Disease (P4.201) (2014) (0)
The Distribution of Phosphorylated Tau in Spinal Cords of Alzheimer’s and Non-Demented Individuals (2013) (0)
SINGLE NUCLEI AND SINGLE WHOLE CELL SEQUENCING OF ALZHEIMER’S DISEASE (2019) (0)
Small rnas in cerebrospinal fluid samples from patients with Alzheimer's disease and neurologically normal controls (2015) (0)
Does loss of interaction of progranulin and prosaposin promote neurofibrillary tangle development? (2020) (0)
A neuroanatomical analysis of the distribution of histopathologic lesions in alzheimer's disease (1991) (0)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
Amyloid (cid:1) peptide load is correlated with increased (cid:1) -secretase activity in sporadic Alzheimer’s disease patients (2004) (0)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005Y2010 (2012) (0)
Vascular Health and Risk Management Cerebral blood flow in Alzheimer ’ s disease (2012) (0)
CHARACTERIZATION OF PROGRANULIN EXPRESSION AND LOCALIZATION IN HUMAN BRAIN TISSUES OF AGED, ALZHEIMER’S DISEASE AND FRONTOTEMPORAL DEMENTIA CASES (2019) (0)
Association Studies of Neuropathologically-Confirmed Cases and Controls Reveals that the PARK10 Locus is a Major Contributor to Sporadic Parkinson disease. (S7.005) (2015) (0)
Author Response: In Vivo Distribution of α-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease (2021) (0)
Clinical Features Of Patients With Concomitant Parkinson’s Disease And Progressive Supranuclear Palsy Pathology (P5.247) (2014) (0)
Abstract 15482: Medin Amyloid Protein-Induced Human Leptomeningeal Arteriole Endothelial Dysfunction and Pro-Inflammatory Signaling are Reversed by Monosialoganglioside Nanoliposomes (2017) (0)
Robust postmortem correlates of florbetapir-PET beta-amyloid imaging of Alzheimer's disease subjects despite neuropathologic heterogeneity (2012) (0)
Biochemical characterization of AN1792-immunized Alzheimer's disease individuals (2010) (0)
RELATIONSHIPS BETWEEN LONGITUDINAL RATES OF LEARNING AND MEMORY DECLINE AND DIFFERENT FORMS OF CEREBROVASCULAR PATHOLOGY IN COGNITIVELY UNIMPAIRED BRAIN DONORS (2019) (0)
Examination of body mass index, organ weights and diagnosed medical conditions in an autopsy series of nondemented individuals and individuals with Alzheimer's disease (2013) (0)
Low Diagnostic Accuracy of a Clinical Diagnosis of Early Parkinson’s Disease: Findings of the Arizona Parkinson’s Disease Consortium (S37.001) (2014) (0)
Neuropathological Validation of the Alzheimer’s Questionnaire (2022) (0)
2160 DIAGNOSIS OF PROSTATE CANCER WITHOUT TUMOR CELLS USING DIFFERENTIALLY EXPRESSED GENES IN THE TUMOR MICROENVIRONMENT (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas Gerald Beach?

Thomas Gerald Beach is affiliated with the following schools: